Mami Matsuda, Asuka Hirai-Yuki, Osamu Kotani, Michiyo Kataoka, Xin Zheng, Daisuke Yamane, Masaru Yokoyama, Koji Ishii, Masamichi Muramatsu, Ryosuke Suzuki. Loxapine inhibits replication of hepatitis A virus in vitro and in vivo by targeting viral protein 2C. PLoS pathogens. 2024. 20. 3. e1012091
Kenzaburo Yamaji, Sadahiro Iwabuchi, Yuko Tokunaga, Shinichi Hashimoto, Daisuke Yamane, Sakiko Toyama, Risa Kono, Bouchra Kitab, Kyoko Tsukiyama-Kohara, Yosuke Osawa, et al. Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023. 166. 115379-115379
Moe Matsumoto, Jennifer L Modliszewski, Kotomi Shinozaki, Reona Maezawa, Vincent M Perez, Yuki Ishikawa, Ryosuke Suzuki, Kevin L McKnight, Takahiro Masaki, Asuka Hirai-Yuki, et al. CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling. Nucleic acids research. 2023. 51. 9. 4451-4466
Jian-Yong Zhao, Xiang-Kun Yuan, Rui-Zhen Luo, Li-Xin Wang, Wei Gu, Daisuke Yamane, Hui Feng. Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction. Frontiers in immunology. 2023. 14. 1107239-1107239
Daisuke Yamane, Yuri Hayashi, Moe Matsumoto, Hiroki Nakanishi, Haruka Imagawa, Michinori Kohara, Stanley M Lemon, Ikuyo Ichi. FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication. Cell chemical biology. 2021